| 01.07 09:20 | dpa-AFX: *IDORSIA +9,9% - EU-ZULASSUNG FÜR BLUTHOCHDRUCK-MITTEL JERAYGO |
| 01.07 08:02 | dpa-AFX: *IDORSIA VORBÖRSLICH +5,6% - EU-ZULASSUNG FÜR BLUTHOCHDRUCK-MITTEL JERAYGO |
| 01.07 07:00 | Press Release: Idorsia's JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertension |
| 01.07 07:00 | Press Release: Idorsia's JERAYGO (aprocitentan) -2- |
| 01.07 07:00 | dpa-AFX: GNW-Adhoc: Idorsia's JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertension |
| 28.06 17:45 | Press Release: Higher cantonal composition authority issues written court decision in respect to the amendments to the terms of the 2024 convertible bonds |
| 28.06 17:45 | dpa-AFX: GNW-Adhoc: Higher cantonal composition authority issues written court decision in respect to the amendments to the terms of the 2024 convertible bonds |
| 25.06 17:45 | Press Release: Higher cantonal composition authority approved the amendments to the terms of the 2024 convertible bonds |
| 25.06 17:45 | dpa-AFX: GNW-Adhoc: Higher cantonal composition authority approved the amendments to the terms of the 2024 convertible bonds |
| 21.06 07:00 | Press Release: Idorsia's novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the 'Primary & Speciality' category |
| 21.06 07:00 | dpa-AFX: GNW-Adhoc: Idorsia's novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the 'Primary & Speciality' category |
| 13.06 11:00 | Press Release: Idorsia holds its Annual General Meeting of Shareholders |
| 13.06 11:00 | dpa-AFX: GNW-Adhoc: Idorsia holds its Annual General Meeting of Shareholders |
| 03.06 07:05 | dpa-AFX: GNW-Adhoc: New data with daridorexant to be presented at SLEEP 2024 |
| 03.06 07:05 | GNW-Adhoc: New data with daridorexant to be presented at SLEEP 2024 |
| 03.06 07:00 | GlobeNewswire/New data with daridorexant to be presented at SLEEP 2024 |
| 03.06 07:00 | Press Release: New data with daridorexant to be presented at SLEEP 2024 |
| 03.06 07:00 | dpa-AFX: GNW-Adhoc: New data with daridorexant to be presented at SLEEP 2024 |
| 31.05 07:05 | dpa-AFX: GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024 |
| 31.05 07:05 | GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024 |
|
|
